Rewired hubs as prognostic markers of liver reperfusion injury

When blood flow returns to a liver that has been deprived of oxygen — during transplantation, after surgical clamping, or following shock resuscitation — the tissue suffers a second, paradoxical wave of damage called ischemia-reperfusion injury. The clinical tools for anticipating this damage are poor: transaminases like ALT peak only after necrosis is established, and the best machine-learning predictor of early allograft dysfunction, a convolutional neural network reading intraoperative photographs of the reperfused graft, reaches an area under the ROC curve of just 0.709 on held-out patients (0.727 when clinical covariates are added) Predicting Early Allograft Dysfunction after Liver Transplantation from Post-Reperfusion Donor Liver Image. This proposal argues that the missing signal is not in the organ's appearance but in the timing of its protein wiring: reperfusion does not simply turn genes on and off, it rewires which proteins physically bind which partners, and the genes whose interaction partners change most across the ischemia-to-reperfusion transition — call them rewired hubs — are the ones worth measuring and worth validating biochemically.

The idea in two sentences: build a time-resolved gene-and-protein interaction network for hepatic ischemia-reperfusion, rank genes not only by how connected they are but by how much their connections change between ischemia, early reperfusion, and late reperfusion, and test whether the top rewired hubs predict graft outcome better than static hub analysis or existing clinical and imaging markers. Then physically verify the rewiring itself, using co-immunoprecipitation — an assay where an antibody against one "bait" protein fishing-lines its binding partners out of a cell lysate — followed by mass spectrometry, on native reperfused liver tissue at each time point.

Core Claim

Static hub-gene analysis is built on a structural bias: it aggregates protein interactions recorded across unrelated tissues and conditions into one "hairball" graph, so a connection that never exists simultaneously in a reperfused liver is treated the same as one that does Detecting temporal protein complexes from dynamic protein-protein interaction networks. Two lines of evidence say this bias matters. In yeast, temporal graph models beat static ones on dynamic interaction benchmarks (95.58% versus 94.35% node-classification accuracy on the DPPIN dataset), showing that edges which appear and disappear carry information static snapshots miss DPPIN: A Biological Dataset of Dynamic Protein-Protein Interaction Networks. And in hepatic reperfusion specifically, the best-characterized injury mechanism is precisely a rewired interaction, not a changed expression level: lactate-primed KAT8 lactylates PCK2, and lactylated PCK2 physically blocks the E3 ubiquitin ligase Parkin from binding OXSM, stabilizing it and driving ferroptosis The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis. None of that axis is visible to a static co-expression network, because the decisive event is post-translational binding competition. My claim is that mechanisms of this shape are common in reperfusion, that a small set of them can be found systematically rather than by candidate screening, and that they carry prognostic information that expression-level markers do not.

Relationship to Prior Work

No study in the corpus bridges all four directions, and the gaps are instructive rather than merely descriptive. The KAT8–PCK2 study used co-immunoprecipitation masterfully in liver reperfusion, but nominated its proteins through candidate screens and mass spectrometry, with no network centrality analysis and no prognostic risk signature — a deep single axis, not a prioritization method. ESPACE reconstructs regulatory networks while deliberately relaxing penalties on hub edges so that true high-degree nodes are not shrunk out of the estimate, and its hubs (CDKN3, AURKA) stratified survival in 442 lung adenocarcinoma patients — but the setting is cancer, the data are static, and no physical interaction was ever tested Enhanced construction of gene regulatory networks using hub gene information. The integrative framework of Padi and Quackenbush is closest in spirit: combining transcriptional networks with physical protein-interaction networks prioritized true master regulators with AUC up to 0.88 in yeast, where plain differential-expression analysis failed outright; but its physical layer came from context-independent repositories (BioGRID, yeast two-hybrid), not from interactions assayed in the perturbed tissue itself Integrating transcriptional and protein interaction networks to prioritize condition-specific master regulators. On the biomarker side, serum miR-381-3p diagnoses ongoing hepatic reperfusion injury with an impressive AUC of 0.925, but it was nominated as a single candidate without network reconstruction, and it diagnoses injury that has already happened rather than forecasting graft outcome Serum miR-381-3p: Diagnostic Role and Mechanisms in Liver Transplant Ischemia-reperfusion Injury. This proposal takes the dynamic-network machinery from the yeast work, the hub-aware estimation from ESPACE, the physical-interaction discipline from the Padi framework, and the co-immunoprecipitation validation standard from the KAT8–PCK2 study, and closes the loop in a way none of them does: condition-specific co-immunoprecipitation data feed back to constrain the dynamic network, which then nominates hubs whose prognostic value is tested clinically.

Research Program

The program has three linked components. First, a computational pipeline that fuses time-course transcriptomics with a static protein-interaction backbone using the sliding-window correlation approach validated on DPPIN, but with hub-aware edge estimation in the spirit of ESPACE — edges attached to candidate hubs receive a relaxed penalty so the network does not artificially demote exactly the nodes we care about DPPIN: A Biological Dataset of Dynamic Protein-Protein Interaction Networks Enhanced construction of gene regulatory networks using hub gene information. Each gene receives a rewiring score, defined as the Jaccard distance between its neighbor sets in consecutive time windows, combined with conventional degree and betweenness centrality. Second, targeted co-immunoprecipitation followed by mass spectrometry on the top-scoring rewired hub (and, as a control, a high-degree but low-rewiring hub) in native liver tissue harvested at end-ischemia, one hour of reperfusion, and six hours of reperfusion, using the 70% lobar ischemia rat model with 30 minutes of clamping and 6 hours of reperfusion as the experimental template Dexmedetomidine ameliorates hepatic ischemia reperfusion injury via modulating SIRT3 mediated mitochondrial quality control. Because lysis mixes cellular compartments and can create interactions that never occurred in vivo, every rewired interaction called from lysates will be cross-checked with a proximity ligation assay, which fluoresces only when two proteins sit within roughly 40 nanometers of each other in intact tissue. Third, a clinical prognostic test: the dynamic-hub signature (expression plus rewiring features) is evaluated for predicting early allograft dysfunction and transaminase recovery trajectories in the existing liver-transplant cohorts — Cohort 1 with 30 patients and Cohort 2 with 247 patients, including 100 propensity-score-matched pairs, in which serum lactate and donor PCK2 expression already correlated with outcome The Lactate‐Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM‐Dependent Mitochondrial Fatty Acid Synthesis.

Proposed Experiments

The method validation runs first, on benchmarks where numbers exist. The dynamic-network component will be benchmarked on the DPPIN yeast dataset against a static graph attention network, which reports 94.35% node-classification accuracy; the temporal graph attention network baseline reports 95.58%, and our pipeline must at least match that gap on the same data before being trusted on mammalian tissue. For temporal complex detection, the reference point is TS-OCD with an f-measure of 0.472 on DIP and recall of 0.741 on BioGRID against the CYC2008 and MIPS gold standards Detecting temporal protein complexes from dynamic protein-protein interaction networks; we will report the same metrics on the same standards for our detection module. For the preclinical experiment, the decisive readout is whether co-immunoprecipitation at the three time points recovers the predicted rewired partners of the top hub at a precision substantially above the ~0.5 f-measure level typical of computational edge prediction, and whether the proximity ligation assay confirms the rewired pairs in situ while rejecting lysis-artifact candidates. As a generality check on a second injury context, the pipeline will be run on the cisplatin acute kidney injury RNA-seq dataset deposited as GSE315580, where NAT10 was found to bind DDX17 by co-immunoprecipitation but was nominated without any centrality analysis NAT10 Promotes Tubular Epithelial Cell Senescence in Cisplatin-Induced Acute Kidney Injury by Regulating DDX17; a useful method should place NAT10 or DDX17 near the top of the rewiring ranking without being told the answer.

Baselines

The naive reference point is the current clinical standard: serum lactate and transaminases measured at reperfusion. The KAT8–PCK2 cohorts showed hyperlactatemia correlates with higher ALT/AST and slower recovery, but no reported result found on Lacuna for a lactate-only prognostic AUC, so we will compute one ourselves on Cohort 2 as the floor any model must clear. The strongest existing competitor for predicting early allograft dysfunction is the CNN reading post-reperfusion donor liver photographs, which reports a testing-set AUC of 0.709, rising to 0.727 in the hybrid model with donor age, operative time, and cold ischemia time, at a sensitivity of only 54% Predicting Early Allograft Dysfunction after Liver Transplantation from Post-Reperfusion Donor Liver Image. It is strongest because it is the only published model on this exact prediction task with a held-out test set; we will compare on the same task, and where possible on overlapping patients, tuning our signature on training data only and reporting a single locked specification on test data, with the same covariates offered to both models so the comparison isolates the molecular signal rather than the clinical variables. Beating it means a DeLong-test-significant AUC improvement over 0.727, or matching its AUC with materially better sensitivity than 54% at the same specificity. The key ablation isolates the proposal's central ingredient: an otherwise identical prognostic pipeline built on a static network, in which rewiring scores are replaced by static intramodular connectivity, exactly the WGCNA-style analysis used in bladder cancer Identification of hub genes in bladder cancer based on weighted gene co‐expression network analysis from TCGA database]. If the dynamic version does not beat the static version on the same samples with the same feature budget, the rewiring ingredient is not earning its place. We will also test an ESPACE-style static reconstruction as a second network ablation, though its reported improvements are in false-discovery-rate and Matthews correlation terms rather than a prognostic AUC, so no reported result found on Lacuna for a directly comparable ESPACE prognostic number.

Why not just…?

Why not just run standard WGCNA on an ischemia-reperfusion cohort? This is the most serious alternative, and I will not argue around it. WGCNA plus hub extraction is cheap, established, and works in cancer prognosis. But two pieces of evidence say it misses the mechanism at stake: Padi and Quackenbush showed that in yeast stress screens the top 10% of differentially expressed genes were depleted of true drivers, so prioritizing by expression-adjacent statistics alone selects passengers Integrating transcriptional and protein interaction networks to prioritize condition-specific master regulators; and the KAT8–PCK2–Parkin–OXSM axis, the single best-validated reperfusion mechanism in the corpus, is invisible to co-expression because its decisive event is a binding competition that changes OXSM degradation without changing any transcript. The static-versus-dynamic ablation above is designed to settle this empirically rather than by argument: if static and dynamic hubs give statistically indistinguishable prognostic AUCs, the static pipeline wins on simplicity and I will say so.

Why not just extend the miR-381-3p or CNN image models? Neither addresses prognosis of graft outcome: miR-381-3p diagnoses injury already occurring (AUC 0.925 for discriminating hepatic reperfusion injury), while the CNN predicts dysfunction but from macroscopic texture alone and tops out at 0.727 Serum miR-381-3p: Diagnostic Role and Mechanisms in Liver Transplant Ischemia-reperfusion Injury. Rather than compete head-on, the proposal treats them as complementary: a planned secondary analysis combines the dynamic-hub signature with the image score and miR-381-3p, testing whether molecular rewiring adds to what the photograph and the circulating microRNA already see. If it adds nothing, that too is a finding about what granularity of measurement prognosis actually requires.

Why not just do co-immunoprecipitation on one strong candidate like PCK2 and dig deeper? That is, in effect, what the KAT8–PCK2 study already did with great rigor; repeating it deepens one axis but answers no prioritization question and produces no generalizable method. The open problem the corpus actually exposes is the inverse: no study has ever used graph-theoretic hub ranking to decide which bait to pull down in reperfused tissue, and no hub-identification study has ever validated its predictions with co-immunoprecipitation in the disease tissue itself. That loop — rank, pull down, feed back — is what this proposal builds.

Decisive Checks

The proposal stands or falls on three numbers. The dynamic pipeline must reproduce the temporal-over-static advantage on DPPIN (95.58% versus 94.35%). The proximity-ligation-confirmed rewired interactions of the top-ranked hub must be substantially more than the co-immunoprecipitation of a matched static hub recovers, establishing that rewiring scores point at real, time-dependent binding. And the dynamic-hub signature must beat the static-network ablation and the hybrid CNN baseline of 0.727 AUC for early allograft dysfunction on held-out transplant patients — or, failing that, must demonstrably add signal when combined with them. Any of the three failing identifies exactly which link in the chain from temporal network to validated prognostic marker is weak.